A novel de novo ACTA1 variant in a patient with nemaline myopathy and mitochondrial Complex I deficiency

[1]  N. Laing,et al.  Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies , 2018, European journal of neurology.

[2]  Beryl B. Cummings,et al.  Nemaline myopathy and distal arthrogryposis associated with an autosomal recessive TNNT3 splice variant , 2018, Human mutation.

[3]  E. Malfatti,et al.  Recessive MYPN mutations cause cap myopathy with occasional nemaline rods , 2017, Annals of neurology.

[4]  R. Frye,et al.  Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment , 2016, Molecular Syndromology.

[5]  J. Finsterer,et al.  Review of Cardiac Disease in Nemaline Myopathy. , 2015, Pediatric neurology.

[6]  Robert W. Taylor,et al.  A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis , 2015, Scientific Reports.

[7]  E. Malfatti,et al.  A Premature Stop Codon in MYO18B is Associated with Severe Nemaline Myopathy with Cardiomyopathy , 2015, Neuromuscular Disorders.

[8]  T. Hortobágyi,et al.  Nemaline Myopathy Type 2 (NEM2) , 2015, Journal of child neurology.

[9]  S. Sandaradura,et al.  Recent advances in nemaline myopathy , 2013, Current opinion in neurology.

[10]  Joanna Poulton,et al.  Pathogenic Mitochondrial tRNA Point Mutations: Nine Novel Mutations Affirm Their Importance as a Cause of Mitochondrial Disease , 2013, Human mutation.

[11]  E. Hardeman,et al.  Distinct underlying mechanisms of limb and respiratory muscle fiber weaknesses in nemaline myopathy. , 2013, Journal of neuropathology and experimental neurology.

[12]  S. Krawitz,et al.  A de novo dominant mutation in ACTA1 causing congenital nemaline myopathy associated with a milder phenotype: Expanding the spectrum of dominant ACTA1 mutations , 2013, Neuromuscular Disorders.

[13]  S. Rahman,et al.  Complex I deficiency: clinical features, biochemistry and molecular genetics , 2012, Journal of Medical Genetics.

[14]  K. North.  Clinical approach to the diagnosis of congenital myopathies. , 2011, Seminars in pediatric neurology.

[15]  S. Calvo,et al.  The molecular basis of human complex I deficiency , 2011, IUBMB life.

[16]  N. Laing,et al.  Nemaline myopathies. , 2011, Seminars in pediatric neurology.

[17]  R. Whittaker,et al.  Mitochondrial diseases in childhood: a clinical approach to investigation and management , 2010, Developmental medicine and child neurology.

[18]  A. Beggs,et al.  Mutations and polymorphisms of the skeletal muscle α‐actin gene (ACTA1) , 2009, Human mutation.

[19]  C. Hawkins,et al.  Nemaline rods and complex I deficiency in three infants with hypotonia, motor delay and failure to thrive. , 2004, Neuropediatrics.

[20]  M. Kornfeld.  Mixed nemaline-mitochondrial “myopathy” , 2004, Acta Neuropathologica.

[21]  H. Budka,et al.  Severe depletion of mitochondrial DNA in spinal muscular atrophy , 2003, Acta Neuropathologica.

[22]  B. Engelen,et al.  A new phenotype of autosomal dominant nemaline myopathy , 2002, Neuromuscular Disorders.

[23]  D. Turnbull,et al.  A novel mitochondrial DNA point mutation in the tRNA(Ile) gene: studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis. , 1998, Biochemical and biophysical research communications.